Probiotic Composition for Weight Loss via Strain Ratio Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current weight loss methods, including drugs and probiotic compositions, often have limited efficacy and can cause adverse reactions, while existing research on Akkermansia muciniphila for weight loss is limited, and the complexity of preparing multi-strain probiotic compositions poses challenges.
Innovation Solution
A microbial composition combining Lactobacillus gasseri and Akkermansia muciniphila in a specific ratio, optimized for weight loss by enhancing the gut microbiota's weight regulation mechanisms, is developed. The composition can be formulated as bacterial powder or fluid and is prepared through culturing and mixing the strains in controlled media.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple bacterial species are used in weight loss composition, then weight loss effect is enhanced, but preparation process complexity increases
Solution Approach 1:
The patent divides the multi-strain probiotic composition into separate preparation processes for each strain (Lactobacillus gasseri, Bifidobacterium longum, Akkermansia muciniphila, etc.), with each strain being cultured, harvested, and formulated independently before final combination. This segmentation allows for optimized preparation of each strain while maintaining the synergistic effects of the complete multi-strain formulation.
2Ease of manufacture
If Akkermansia muciniphila is used alone for weight loss, then the preparation is simple, but the weight loss effect is limited
Solution Approach 1:
The patent combines Akkermansia muciniphila with multiple other probiotic strains including Lactobacillus gasseri, Bifidobacterium longum, and Lactobacillus rhamnosus in a synergistic formulation. This merging of different probiotic strains enhances the weight loss effect beyond what Akkermansia muciniphila can achieve alone, while maintaining a relatively streamlined preparation process by using standardized culturing protocols for each strain.
3Reliability
If existing weight loss drugs are used, then weight loss effect can be achieved, but adverse reactions occur
Solution Approach 1:
The patent converts the approach from using synthetic pharmaceutical drugs with known side effects to using probiotic microorganisms that naturally inhabit the human gut. By utilizing beneficial bacteria like Lactobacillus gasseri and Akkermansia muciniphila, the formulation achieves weight loss effects through natural physiological mechanisms (regulating gut microbiota, improving metabolism) rather than pharmacological intervention, thereby eliminating the adverse reactions associated with conventional weight loss drugs.
Data Source
AI summary
The invention provides a microbial composition with weight loss efficacy, the microbial composition including Lactobacillus gasseri and Akkermansia muciniphila; a ratio of the Lactobacillus gasseri and the Akkermansia muciniphila is 2:3-3:2 by viable counts. By probiotic composition containing a specific proportion and content of Lactobacillus gasseri and Akkermansia muciniphila, it is able to improve body weight abnormalities caused by metabolic diseases.